GREEN CROSS

Search
Keyword Search
Plasma Derivatives Office Vaccines Subsidiary Pipeline R&D Media Stock Company Recruit
Product Search
close
Total Menu KOR
close

InvestorsFinancial Highlights

The following figures represent the performance of Green Cross, the leading member of the Green Cross Holdings and holder of the group’s key businesses.

As of 2016, not consolidated

  • Average rate of growth in company revenue over the past three years

    9.2%
  • Average proportion of revenue reinvested in R&D over the past three years

    10.8%
  • Annual rate of increase in the number of employees [1]

    11.7%
  • Annual rate of increase in the number of R&D specialists [2]

    19.4%
  • The highest credit rating given to a Korean pharmaceutical company for its corporate bonds.

    AA-
  • Payout ratio

    22.7%
  1. 1  
    Green Cross continues to harness its sales and R&D divisions to ensure continued growth.
  2. 2  
    Green Cross continues to hire an increasing number of talented research specialists as part of its efforts to strengthen its R&D capabilities.